Completed NA INTERVENTIONAL 2-arm NCT01043588

TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management (REVAPRO)

Transurethral Resection of the Prostate With Photo Selective Vaporization of the Prostate Using the High Powered 532nm Laser Obstructive Benign Prostatic Hyperplasia Management: Focus on Efficiency and Cost-effectiveness

Sponsor: American Medical Systems

Conditions Benign Prostatic Hyperplasia

Interventions PVP TURP

Updated 5 times since 2017 Last updated: Apr 30, 2013 Started: Nov 30, 2007 Primary completion: Dec 31, 2009 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01043588, this NA trial focuses on Benign Prostatic Hyperplasia and remains completed. Sponsored by American Medical Systems, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Medical Systems
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France